度洛西汀治疗一名成人注意力缺陷多动障碍患者的疗效改善情况。
Improvement with duloxetine in an adult ADHD patient.
作者信息
Tourjman Smadar Valérie, Bilodeau Mathieu
机构信息
University of Montréal, Psychiatrist Centre Hospitalier Universitaire de Montréal.
出版信息
J Atten Disord. 2009 Jul;13(1):95-6. doi: 10.1177/1087054708326109. Epub 2009 Apr 9.
INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD) is a common and disabling disorder among adults and is treated with stimulant and non stimulant medication.
OBJECTIVE
To report the case of a patient with ADHD showing good clinical response to duloxetine, a selective serotonin and norepinephrine reuptake inhibitor (SSNRI).
CASE PRESENTATION
A 53 year-old man with a recently diagnosed ADHD was successfully treated with duloxetine 60 mg and showed reduced scores on the Conners' Adult ADHD Rating Scales - Self-Report Scale: Short Version (CAARS-S:S).
CONCLUSION
Duloxetine could be an option for patients who either do not tolerate or show resistance to more common pharmacological choices. Randomized controlled trials are needed to assess the efficacy of duloxetine in treating ADHD symptoms.
引言
注意力缺陷多动障碍（ADHD）是成年人中一种常见的致残性疾病，可用兴奋剂和非兴奋剂药物治疗。
目的
报告一例ADHD患者对选择性5-羟色胺和去甲肾上腺素再摄取抑制剂（SSNRI）度洛西汀有良好临床反应的病例。
病例介绍
一名53岁近期诊断为ADHD的男性患者用60毫克度洛西汀成功治疗，在康纳斯成人ADHD评定量表-自我报告量表：简版（CAARS-S:S）上得分降低。
结论
对于不耐受或对更常用药物选择有抵抗的患者，度洛西汀可能是一种选择。需要进行随机对照试验来评估度洛西汀治疗ADHD症状的疗效。
Zotero 插件